VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Pharmaceutical
Revenues at Almirall, Spain’s largest drugmaker, were 11.5% lower in the first half of 2017 than in the previous year, its latest financial figures show. 24 July 2017
Pharmaceutical
Trying to control investor and media relations for Anglo-Swedish pharma major AstraZeneca remains an unenviable task, with leaks now appearing to suggest that chief executive Pascal Soriot is staying. 24 July 2017
Pharmaceutical
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime compared to Tuesday’s close, with the company considering what to do with new-found success. 21 July 2017
Biotechnology
The pharmaceutical industry is one of the UK’s great success stories, writes Michael Jewell, healthcare partner at Cavendish Corporate Finance, in an Expert View piece on how the sector could see an increase in deal-making as Brexit looms. 20 July 2017
Pharmaceutical
US health care giant Johnson & Johnson was 1.3% up at $133.91 on Tuesday lunchtime after investors reacted positively to the presentation of its 2nd-qtr results, although sales in its pharma segment were in fact down on a year ago. 18 July 2017
Pharmaceutical
Novartis’ shares were up 2.25% at 81.95 Swiss francs in morning trading, after the company posted second-quarter 2017 financial results that beat expectations, and reiterated its forecast that sales would start growing again in 2018. 18 July 2017
Pharmaceutical
The UK government is to provide £86 million in funding to support British firms in developing medical technologies. 14 July 2017
Pharmaceutical
Monday has been a painful day for Almirall, Spain’s largest drugmaker, which looked set to close the day’s trading having lost a quarter of its share value. 10 July 2017
Pharmaceutical
UK drugmaker GlaxoSmithKline will be hoping for a stabilization in its share price on Thursday afternoon after a significant slide was started by a broker downgrading its stock recommendation. 6 July 2017
Pharmaceutical
American diabetes startup Diasome Pharmaceuticals has received up to $30 million in funding from a group of four investors, led by British life science venture capitalists Medicxi. 6 July 2017
Biotechnology
A Californian startup focused on oncology, Vivace Therapeutics, has raised $25 million in series B funding from a mainly Chinese consortium of investors. 5 July 2017
Biotechnology
A US biotech which calls itself the pioneer of a ‘new class of extraordinarily active and differentiated cell therapies’ has raised $120 million in a highly oversubscribed private financing. 22 June 2017
Pharmaceutical
In a battle which commentators might observe embodies a wider conflict of its time, the row engulfing Netherlands-incorporated drugmaker Mylan has entered another ugly round. 13 June 2017
Pharmaceutical
Positive results could propel the company into the top tier of immuno-oncology drugmakers, pharma’s fastest developing space, but a bad outcome could leave its status as a big pharma player in serious doubt. 12 June 2017
Biotechnology
Swiss biotech firm Actelion has published the listing prospectus relating to the listing of Idorsia shares on the SIX Swiss Exchange. 10 June 2017
Biotechnology
US immuno-oncology specialist NewLink Genetics lost 41% of its value on Thursday after Swiss pharma giant Roche’s Genentech unit handed back the rights to the cancer candidate GDC-0919 (navoximod). 9 June 2017
Pharmaceutical
Mylan is fighting battles on multiple fronts, including over price increases of its EpiPen (epinephrine) devices and as it races to market with its biosimilar products. 7 June 2017
Biotechnology
Chinese healthcare investment firms Frontline BioVentures and WuXi Healthcare Ventures are to merge, creating a venture capital giant with combined assets under management of 5.5 billion renminbi, or $800 million. 30 May 2017
Biotechnology
Privately-held US biotech firm Palladio Biosciences has bought the global rights to lixivaptan from the American arm of Chiesi Farmaceutici. 24 May 2017
Biotechnology
Taking in and making use of key findings from conferences can be a difficult task but industry veteran Shawn Manning, managing director of investment banking firm Outcome Capital, came away from this month’s BioTrinity 2017 in the UK with some important learnings on the life sciences sector at present. 22 May 2017
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze